Healthcare M&A looks set to be strong again this year, following deals from Shire and Roche. But Goldman Sachs says energy's a sector to watch too.» Read More
Stocks opened lower Tuesday, after soaring to new 2009 highs on Monday, as a report showed the economy grew less than expected in the third quarter.
What follows is a roundup of corporate earnings reports for Tuesday, Nov. 24.
So far in today's trading session, a total of 31 stocks in the S&P 500 have reached new 52-week highs. Here is a look at those companies.
On Saturday, the House backed a health care bill that would expand coverage to nearly all Americans and bar insurance practices such as refusing to cover people with pre-existing medical conditions. How should investors be positioned? Bob Phillips, managing partner at Spectrum Management Group and Robert Zagunis, co-portfolio manager at Jensen Investment Management shared their insights.
Global stock markets are higher overnight due to...Australia? Yep. The central bank there became the first G20 country to raise interest rates, by 25 basis points to 3.25 points. The Australian dollar jumped to a 14-month high, and stocks rose as well.
A race is on to develop the potentially next big thing in heart surgery: a replacement valve that can be implanted through thin tubes known as catheters rather than by traditional open-heart surgery.
Cramer makes the call on viewers' favorite stocks.
The Lightning Round is extended in this CNBC.com exclusive feature.
Boston Scientific has rallied back to its highest levels since last year's financial crisis and is scheduled to discuss a key defibrillator trial this morning, prompting one large investor to position for a potential decline.
Author Matthew May lays down the gauntlet with this beautiful challenge, "Savvy innovators understand that what isn’t there can often trump what is there."
The market traded sideways on Tuesday with Dow finishing slightly lower and the S&P 500 closing a little higher.
Russia's RTS Index was the first global index to hit the correction stage (down 23 percent since hitting its recent high on June 2nd), but now the MSCI Emerging Markets Index (EEM in its ETF form) is also down double-digits since hitting its recent high on June 1st.
Medtronic said on Wednesday that it had paid nearly $800,000 over an eight-year period to a former military surgeon who has been accused by the Army of falsifying a medical journal study involving one of the company’s products.
Medtronic spokesman Steve Cragle sent CNBC this clarification to Mr. Hawkins' answer to Mike Huckman's question regarding the Senate investigation into a doctor who has done consulting work for MDT.
Medtronic may have set a record. The world's biggest medical device maker put out six press releases this morning.
Futures dropped as housing starts for April came in at 458,000, well below expectations of 520,000, and permits came in at 494,000, also well below expectations of 530,000. However, most of the drop is attributable to lower multifamily construction; single family starts and permits rose, though they are still low.
How does a five-star fund manager approach investing when uncertainty is high? “Every recession we’ve had has ended and this one will end as well,” said Robert Zagunis, 5-star portfolio manager at Jensen Investment Management.
This takes the prize for the most dangerously optimistic acronym for a clinical trial. But MADIT (pronounced "made it") made it. Some folks with a lot of chutzpah at Guidant, now owned by Boston Scientific, apparently came up with the name for their big studies on implantable cardio defibrillators.
The recession is likely to continue throughout the year, but valuations for stocks are looking attractive right now, said Jack Liebau, president and portfolio manager at Liebau Asset Management.
Plus, Cramer makes the call on retail, health care and more.